Clinical Trial Update: Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study update of ARO-HBV in healthy volunteers and patients with Hepatitis B, with results posted in June 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ARO-HBV

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-06-04